Apellis Pharmaceuticals Cash Flow Statement (2020-2025) | APLS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -100.43M-121.39M-138.38M120.70M-183.66M-219.19M-195.57M-147.93M-138.94M-155.98M-191.27M-165.99M-177.80M-122.04M-140.24M-88.58M-66.45M-37.66M-57.45M-36.33M-92.22M-42.19M215.72M
Depreciation and Depletion 0.09M0.10M0.19M0.27M0.28M0.44M0.28M0.37M0.38M0.39M0.40M0.39M0.42M0.42M0.46M0.48M0.44M0.45M0.46M0.45M0.45M0.45M0.34M
Share-based Compensation 9.29M11.49M12.10M12.49M16.44M17.72M17.19M19.31M20.77M22.53M23.54M24.24M28.82M29.28M21.62M26.22M30.35M29.99M27.48M26.31M27.37M27.20M28.19M
Gains from Sales and Divestitures 0.13M0.37M1.01M1.42M
Gains from Investment Securities 0.46M0.06M0.00M17.34M-11.95M9.19M6.71M8.83M-15.63M-0.12M-0.13M-1.60M-14.97M-0.01M0.17M3.11M-0.10M0.40M-0.23M-0.79M-0.20M-0.06M6.72M
Non-cash Items 100.10M291.82M317.03M253.93M6.71M
Cash from Operations -108.35M-94.29M-99.82M141.98M-153.31M-128.69M-168.62M-112.50M-111.56M-107.02M-154.42M-140.74M-177.62M-150.16M-169.09M-97.88M-132.98M-8.34M34.10M19.36M-53.41M4.45M108.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.06M0.03M0.12M14.77M0.36M-0.24M-0.01M0.00M
Amortization of Deferred Charges 0.06M0.03M0.12M0.01M0.11M0.01M-0.01M0.00M
Depreciation & Amortization (CF) 0.09M0.10M0.19M0.27M0.28M0.44M0.28M0.37M0.38M0.39M0.40M0.39M0.42M0.42M0.46M0.48M0.44M0.45M0.46M0.45M0.45M0.45M0.34M
Change in Working Capital
Change in Receivables 1.90M7.49M-3.77M1.19M0.57M-0.36M23.78M79.41M58.36M37.17M61.41M36.58M-25.42M-14.09M-29.68M-21.12M131.40M
Change in Inventory -2.05M14.64M16.53M15.60M11.30M25.96M-0.14M17.65M-4.67M47.82M14.92M14.51M-8.65M-10.02M-14.00M26.01M-5.40M
Change in Account Payables -5.24M6.84M0.79M-2.45M-4.17M0.87M0.08M13.70M-6.37M8.96M-7.03M23.13M-5.85M-4.00M-9.60M19.62M-10.73M11.49M-1.16M1.49M16.71M-1.04M-15.64M
Change in Accured Expenses -9.99M0.42M13.62M51.00M-42.80M65.32M-64.61M31.70M3.65M-20.94M-3.98M14.95M-23.47M26.54M20.03M11.85M-26.33M22.02M16.38M6.08M-30.16M22.88M7.08M
Change in Taxes 0.26M-0.14M
Other Working Capital Changes 3.00M-4.88M-6.63M34.79M5.82M1.65M-14.15M47.60M2.31M-44.54M-3.23M12.52M-2.31M-7.54M17.53M-21.92M-10.70M0.66M-4.98M-5.40M18.73M-7.95M2.38M
Investing Activities
Capital Expenditures 0.43M0.54M3.74M0.71M0.48M0.25M0.35M0.02M0.09M0.39M0.20M0.85M0.26M0.37M0.05M0.10M0.29M0.09M0.02M0.01M0.05M0.15M
Change in Acquisitions & Divestments 202.50M312.50M25.00M130.00M180.00M85.00M60.00M83.32M124.98M124.98M
Cash from Investing Activities -227.85M-287.81M198.76M-0.09M-146.76M129.75M179.65M84.98M-271.95M82.93M124.78M124.13M-0.26M-0.37M-0.05M0.00M-0.29M-0.09M-0.02M-0.01M-0.05M-0.15M
Financing Activities
Cash from Financing Activities 403.27M281.67M0.93M6.32M1.63M4.53M2.12M383.96M376.70M-4.74M9.64M-15.95M391.11M1.56M5.75M-3.91M108.21M42.49M2.54M-4.00M0.27M6.56M0.79M
Additional items
Exchange Rate Effect -0.15M0.13M-1.65M2.02M-1.61M-0.24M-0.17M0.01M0.06M-0.43M-0.31M0.19M0.06M-0.05M-0.46M0.58M-0.21M0.34M0.17M-0.96M0.36M0.69M0.02M
Change in Cash 66.91M-100.30M98.22M150.23M-300.06M5.35M12.97M356.45M-6.74M-29.26M-20.31M-32.37M213.28M-149.01M-163.84M-101.20M-25.27M34.40M36.81M14.38M-52.78M11.64M109.14M
Beginning Cash Balance 350.97M417.65M317.34M415.55M565.49M265.42M270.77M283.75M640.20M633.75M604.50M584.17M551.80M765.27M616.26M452.38M351.20M325.69M360.05M396.92M411.19M358.40M370.06M
Free Cash Flow -108.78M-94.83M-103.56M141.27M-153.80M-128.94M-168.98M-112.52M-111.65M-107.42M-154.61M-141.59M-177.88M-150.53M-169.13M-97.97M-133.28M-8.43M34.10M19.34M-53.42M4.40M108.32M
Net Cash Flow 67.06M-100.43M99.86M148.21M-298.45M5.59M13.14M356.44M-6.80M-28.83M-20.00M-32.56M213.23M-148.97M-163.39M-101.78M-25.06M34.06M36.64M15.34M-53.14M10.95M109.11M